These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 14597234)
1. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist. Guarna M; Bartolini A; Ghelardini C; Galeotti N; Bracci L; Stefano GB; Bianchi E Brain Res Mol Brain Res; 2003 Nov; 119(1):100-10. PubMed ID: 14597234 [TBL] [Abstract][Full Text] [Related]
2. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. Xu H; Wang X; Wang J; Rothman RB Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220 [TBL] [Abstract][Full Text] [Related]
3. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence. Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090 [TBL] [Abstract][Full Text] [Related]
4. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
5. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors. Olianas MC; Concas D; Onali P Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046 [TBL] [Abstract][Full Text] [Related]
6. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins. Melkes B; Hejnova L; Novotny J Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870 [TBL] [Abstract][Full Text] [Related]
7. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse. Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor. Zhang D; Li JG; Chen C; Liu-Chen LY Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435 [TBL] [Abstract][Full Text] [Related]
9. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM; Qian X; Schiller PW; Szeto HH J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366 [TBL] [Abstract][Full Text] [Related]
10. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner. Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705 [TBL] [Abstract][Full Text] [Related]
11. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide. Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687 [TBL] [Abstract][Full Text] [Related]
13. ABIN-1 Negatively Regulates Zhou P; Jiang J; Yan H; Li Y; Zhao J; Wang X; Su R; Gong Z Mol Pharmacol; 2018 Feb; 93(2):36-48. PubMed ID: 29237725 [TBL] [Abstract][Full Text] [Related]
14. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells. Cinar R; Szücs M J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142 [TBL] [Abstract][Full Text] [Related]
15. Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors. Perret BG; Wagner R; Lecat S; Brillet K; Rabut G; Bucher B; Pattus F Protein Expr Purif; 2003 Sep; 31(1):123-32. PubMed ID: 12963349 [TBL] [Abstract][Full Text] [Related]
16. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors. Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532 [TBL] [Abstract][Full Text] [Related]
20. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays. Márki A; Monory K; Otvös F; Tóth G; Krassnig R; Schmidhammer H; Traynor JR; Roques BP; Maldonado R; Borsodi A Eur J Pharmacol; 1999 Oct; 383(2):209-14. PubMed ID: 10585536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]